# Biotech Daily Digest — 2026-01-14

**35 items from 5 sources**

## Summary by Source

- Eli Lilly Press Releases: 5 items
- Endpoints News: 5 items
- Fierce Biotech: 4 items
- MHRA – News: 1 item
- arXiv q-bio: 20 items


## Eli Lilly Press Releases

- **[Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance](https://investor.lilly.com/news-releases/news-release-details/lilly-reports-third-quarter-2025-financial-results-highlights-rd)**  
  _Thu, 30 Oct 2025 06:45:00 -0400_  
  Revenue in Q3 2025 increased 54% to $17.60 billion driven by volume growth from Mounjaro and Zepbound . Q3 2025   EPS increased by $5.14 to $6.21 on a reported basis and increased by $5.84 to $7.02 on a non-GAAP basis. Increased our 2025 full-year revenue guidance to be in the range of $63.0

- **[Lilly declares fourth-quarter 2025 dividend](https://investor.lilly.com/news-releases/news-release-details/lilly-declares-fourth-quarter-2025-dividend)**  
  _Mon, 27 Oct 2025 14:00:00 -0400_  
  INDIANAPOLIS , Oct. 27, 2025 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2025 of $1.50 per share on outstanding common stock. The dividend is payable on December 10, 2025 , to shareholders of record at the close of

- **[Lilly to Acquire Adverum Biotechnologies](https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-adverum-biotechnologies)**  
  _Fri, 24 Oct 2025 08:30:00 -0400_  
  Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate

- **[Lilly confirms date and conference call for third-quarter 2025 financial results announcement](https://investor.lilly.com/news-releases/news-release-details/lilly-confirms-date-and-conference-call-third-quarter-2025)**  
  _Thu, 16 Oct 2025 10:00:00 -0400_  
  INDIANAPOLIS , Oct. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2025 financial results on October 30, 2025 . Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial

- **[Lilly to participate in Bernstein's 2nd Annual Healthcare Forum](https://investor.lilly.com/news-releases/news-release-details/lilly-participate-bernsteins-2nd-annual-healthcare-forum)**  
  _Thu, 11 Sep 2025 10:00:00 -0400_  
  INDIANAPOLIS , Sept. 11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Bernstein's 2nd Annual Healthcare Forum on September 25, 2025 . Lucas Montarce, executive vice president and chief financial officer, will take part in a fireside chat at 8 a.m., Eastern time .


## Endpoints News

- **[Caldera Therapeutics erupts with $112.5M and a China-originated IBD bispecific](https://endpoints.news/caldera-therapeutics-erupts-with-112-5m-and-a-china-originated-ibd-bispecific/)**  
  _Wed, 14 Jan 2026 12:00:39 +0000_  
  After selling Morphic Therapeutic to Eli Lilly for $3.2 billion, Praveen Tipirneni is back a year and a half later with a new biotech working in Morphic's old wheelhouse of inflammatory bowel ...

- **[#JPM26: Day 3 at the JP Morgan Healthcare Conference](https://endpoints.news/jpm26-day-3-at-the-jp-morgan-healthcare-conference/)**  
  _Wed, 14 Jan 2026 12:00:12 +0000_  
  It’s Wednesday at the JP Morgan Healthcare Conference, and as the sessions wind down, we’ll be keeping an eye on presentations from WuXi AppTec and AbbVie.

 Yesterday afternoon, our Executive Editor Drew Armstrong spoke with ...

- **[#JPM26: Q&A with Bristol Myers Squibb CEO Chris Boerner on 2026 outlook](https://endpoints.news/jpm26-qa-with-bristol-myers-squibb-ceo-chris-boerner-on-2026-outlook/)**  
  _Wed, 14 Jan 2026 11:45:48 +0000_  
  SAN FRANCISCO — In his third year as CEO of Bristol Myers Squibb, Chris Boerner kicked off the JP Morgan Healthcare Conference with plans for six pivotal readouts of new drugs ...

- **[FDA delays decision on expanding label for Travere's kidney disorder drug](https://endpoints.news/fda-delays-decision-on-expanding-label-for-traveres-kidney-disorder-drug/)**  
  _Tue, 13 Jan 2026 21:19:40 +0000_  
  The FDA is extending its review of Travere’s drug for a rare kidney disorder by three months.

 The agency was expected to decide by today on Travere's application to market Filspari in focal segmental glomerulosclerosis ...

- **[FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels](https://endpoints.news/fda-asks-lilly-novo-to-remove-suicide-warnings-from-glp-1-labels/)**  
  _Tue, 13 Jan 2026 19:00:55 +0000_  
  The FDA asked Novo Nordisk and Eli Lilly to remove warnings about suicidal ideation or behavior from the labels of their blockbuster GLP-1 weight loss drugs.

 Novo's Saxenda and Wegovy, as well as Lilly's Zepbound ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/medtech/jpm26-illumina-working-china-path-through-its-export-troubles-sees-academic-research" hreflang="en">JPM26: Illumina working with China on 'a path through' its export troubles, sees academic research environment 'muted' for '26</a>](https://www.fiercebiotech.com/medtech/jpm26-illumina-working-china-path-through-its-export-troubles-sees-academic-research)**  
  _Jan 14, 2026 1:58am_  
  Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the country’s Unreliable Entities List.

- **[<a href="https://www.fiercebiotech.com/biotech/jpm-lenacapavir-momentum-builds-gilead-eyes-new-deals-position-strength" hreflang="en">JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength'</a>](https://www.fiercebiotech.com/biotech/jpm-lenacapavir-momentum-builds-gilead-eyes-new-deals-position-strength)**  
  _Jan 13, 2026 5:51pm_  
  Still riding the high of last year’s twice-yearly HIV PrEP approval of lenacapavir as Yeztugo, Gilead Sciences is approaching deal-making from a “position of strength” as a more mature biopharma, CEO Daniel O’Day told journalists on the sidelines of the 2026 J.P. Morgan Healthcare Conference in San Francisco.

- **[<a href="https://www.fiercebiotech.com/pharma/jpm-2026-leo-pharma-hungry-more-partnerships-looks-widen-field-rare-dermatology-diseases" hreflang="en">JPM26: Leo Pharma, hungry for more partnerships, looks to widen reach in rare dermatology diseases</a>](https://www.fiercebiotech.com/pharma/jpm-2026-leo-pharma-hungry-more-partnerships-looks-widen-field-rare-dermatology-diseases)**  
  _Jan 13, 2026 2:49am_  
  Leo Pharma CEO Christophe Bourdon is eager to make additional strides on the new era of growth he’s fostered since taking over in 2022, he said in an interview on the sidelines of the J.P. Morgan Healthcare Conference.

- **[<a href="https://www.fiercebiotech.com/biotech/fierce-biotechs-jpm26-tracker-day-2" hreflang="en">JPM26, Day 2: Novartis pays $50M cash for China biotech program; AZ acquires AI partner</a>](https://www.fiercebiotech.com/biotech/fierce-biotechs-jpm26-tracker-day-2)**  
  _Jan 13, 2026 8:49am_  
  The J.P. Morgan Healthcare Conference is rolling on Tuesday with many more conference-related events on the docket, including the start of Fierce JPM Week. Our reporters and editors are on the ground in San Francisco and will keep you updated with all the latest.


## MHRA – News

- **[Transparency data: Medicines and Healthcare products Regulatory Agency Privacy Notice](https://www.gov.uk/government/publications/mhra-privacy-notice)**  
  _2026-01-14T09:26:45Z_  
  This privacy notice describes how we collect and use your personal information, in accordance with the Data Protection Act and the General Data Protection Regulation.


## arXiv q-bio

- **[Plasma-Activated Zn, Fe, Mn Micronutrient Solutions for Crop Biofortification](https://arxiv.org/abs/2601.07847)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07847v1 Announce Type: new 
Abstract: Micronutrient deficiency in soils limits crop productivity and reduces the nutritional quality of cereals and pulses. Conventional fertilizer supplementation often suffers from low bioavailability and environmental losses. In this study, we investigate the use of Plasma…

- **[From local defects to shear-organized biofilms in tonsillar crypts via computational simulations](https://arxiv.org/abs/2601.07863)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07863v1 Announce Type: new 
Abstract: Biofilms in human tonsillar crypts show long term persistence with episodic dispersal that current biochemical and microbiological descriptions do not fully explain, particularly with respect to spatial localization. We introduce a biophysical framework in which tonsill…

- **[Imaging-anchored Multiomics in Cardiovascular Disease: Integrating Cardiac Imaging, Bulk, Single-cell, and Spatial Transcriptomics](https://arxiv.org/abs/2601.07871)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07871v1 Announce Type: new 
Abstract: Cardiovascular disease arises from interactions between inherited risk, molecular programmes, and tissue-scale remodelling that are observed clinically through imaging. Health systems now routinely generate large volumes of cardiac MRI, CT and echocardiography together…

- **[The embodied brain: Bridging the brain, body, and behavior with neuromechanical digital twins](https://arxiv.org/abs/2601.08056)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08056v1 Announce Type: new 
Abstract: Animal behavior reflects interactions between the nervous system, body, and environment. Therefore, biomechanics and environmental context must be considered to dissect algorithms for behavioral control. This is enabled by leveraging neuromechanical digital twins: compu…

- **[Network Pharmacology Framework Characterizes Polypharmacological Properties of Dietary Flavonoids: Integration of Computational, Experimental, and Epidemiological Evidence](https://arxiv.org/abs/2601.08147)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08147v1 Announce Type: new 
Abstract: Dietary flavonoids associate with disease prevention in epidemiological studies, yet their polypharmacological mechanisms remain unclear. We establish network pharmacology as a systematic framework to characterize flavonoid therapeutic properties through integrated comp…

- **[An open-source computational framework for immersed fluid-structure interaction modeling using FEBio and MFEM](https://arxiv.org/abs/2601.08266)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08266v1 Announce Type: new 
Abstract: Fluid-structure interaction (FSI) simulation of biological systems presents significant computational challenges, particularly for applications involving large structural deformations and contact mechanics, such as heart valve dynamics. Traditional ALE methods encounter…

- **[Training Under Attentional Competition Produces Persistent Biases in Visual Appearance](https://arxiv.org/abs/2601.08285)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08285v1 Announce Type: new 
Abstract: Selective attention can momentarily alter visual appearance, but can such effects be learned? We tested whether training attention under sensory competition produces lasting changes in perceived contrast. Across seven days, participants trained on an orientation task wi…

- **[Disentangling History and Propagation Dependencies in Cross-Subject Knee Contact Stress Prediction Using a Shared MeshGraphNet Backbone](https://arxiv.org/abs/2601.08318)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08318v1 Announce Type: new 
Abstract: Background:Subject-specific finite element analysis accurately characterizes knee joint mechanics but is computationally expensive. Deep surrogate models provide a rapid alternative, yet their generalization across subjects under limited pose and load inputs remains unc…

- **[Tara Polaris expeditions: Sustained decadal observations of the coupled Arctic system in rapid transition](https://arxiv.org/abs/2601.08370)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08370v1 Announce Type: new 
Abstract: The coupled Arctic system is in rapid transition and is set to undergo further dramatic changes over the coming decades. These changes will lead most likely to an ice-free ocean in summer, expected before mid-century. The Arctic will become more strongly influenced by a…

- **[Beta-coalescents when sample size is large](https://arxiv.org/abs/2601.08538)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08538v1 Announce Type: new 
Abstract: Sweepstakes reproduction refers to a highly skewed individual recruitment success without involving natural selection and may apply to individuals in broadcast spawning populations characterised by Type III survivorship. We consider an extension of the model of sweepsta…

- **[Automated Lesion Segmentation of Stroke MRI Using nnU-Net: A Comprehensive External Validation Across Acute and Chronic Lesions](https://arxiv.org/abs/2601.08701)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08701v1 Announce Type: new 
Abstract: Accurate and generalisable segmentation of stroke lesions from magnetic resonance imaging (MRI) is essential for advancing clinical research, prognostic modelling, and personalised interventions. Although deep learning has improved automated lesion delineation, many exi…

- **[Gyral-Sulcal-Net: An Integrated Network Representation of Brain Folding Patterns](https://arxiv.org/abs/2601.08818)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08818v1 Announce Type: new 
Abstract: Our brain functions as a complex communication network, and studying it from a network perspective offers valuable insights into its organizational principles and links to cognitive functions and brain disorders. However, most current network studies typically use brain…

- **[Crossing the Functional Desert: Critical Cascades and a Feasibility Transition for the Emergence of Life](https://arxiv.org/abs/2601.06272)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06272v1 Announce Type: cross 
Abstract: The origin of life poses a problem of combinatorial feasibility: How can persistent functional organization arise in exponentially branching assembly spaces when unguided exploration behaves as a memoryless random walk? We show that nonlinear threshold-cascade dynamic…

- **[Combinatorial comparison of general galled trees, time-consistent galled trees, and simplex time-consistent galled trees](https://arxiv.org/abs/2601.08062)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08062v1 Announce Type: cross 
Abstract: Rooted binary phylogenetic networks are extensions of rooted binary trees, adding reticulation nodes that are designed to represent evolutionary processes that involve hybridization events. Enumerative combinatorics studies have counted leaf-labeled phylogenetic netwo…

- **[A whole-brain model of amyloid beta accumulation and cerebral hypoperfusion in Alzheimer's disease](https://arxiv.org/abs/2601.08478)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08478v1 Announce Type: cross 
Abstract: Accumulation of amyloid beta proteins is a defining feature of Alzheimer's disease, and is usually accompanied by cerebrovascular pathology. Evidence suggests that amyloid beta and cerebrovascular pathology are mutually reinforcing; in particular, amyloid beta suppres…

- **[Stable Filtering for Efficient Dimensionality Reduction of Streaming Manifold Data](https://arxiv.org/abs/2601.08685)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08685v1 Announce Type: cross 
Abstract: Many areas in science and engineering now have access to technologies that enable the rapid collection of overwhelming data volumes. While these datasets are vital for understanding phenomena from physical to biological and social systems, the sheer magnitude of the d…

- **[Near-perfect photo-ID of the Hula painted frog with zero-shot deep local-feature matching](https://arxiv.org/abs/2601.08798)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2601.08798v1 Announce Type: cross 
Abstract: Accurate individual identification is essential for monitoring rare amphibians, yet invasive marking is often unsuitable for critically endangered species. We evaluate state-of-the-art computer-vision methods for photographic re-identification of the Hula painted frog…

- **[Modulating task outcome value to mitigate real-world procrastination via noninvasive brain stimulation](https://arxiv.org/abs/2506.21000)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2506.21000v2 Announce Type: replace 
Abstract: Procrastination represents one of the most prevalent behavioral problems affecting individual health and societal productivity. Although it is often conceptualized as a form of self-control failure, its underlying neurocognitive mechanisms are poorly understood. A l…

- **[Stochastic synaptic dynamics under learning](https://arxiv.org/abs/2508.13846)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2508.13846v3 Announce Type: replace 
Abstract: Learning is based on synaptic plasticity, which affects and is driven by neural activity. Because pre- and postsynaptic spiking activity is shaped by randomness, the synaptic weights follow a stochastic process, requiring a probabilistic framework to capture the noi…

- **[Engineering Spatial and Molecular Features from Cellular Niches to Inform Predictions of Inflammatory Bowel Disease](https://arxiv.org/abs/2509.09923)**  
  _Wed, 14 Jan 2026 00:00:00 -0500_  
  arXiv:2509.09923v2 Announce Type: replace 
Abstract: Differentiating between the two main subtypes of Inflammatory Bowel Disease (IBD): Crohns disease (CD) and ulcerative colitis (UC) is a persistent clinical challenge due to overlapping presentations. This study introduces a novel computational framework that employs…
